Cargando…
Liquid-based biomarkers in breast cancer: looking beyond the blood
In recent decades, using circulating tumor cell (CTC), circulating tumor DNA (ctDNA), circulating tumor RNA (ctRNA), exosomes and etc. as liquid biomarkers has received enormous attention in various tumors, including breast cancer (BC). To date, efforts in the area of liquid biopsy predominantly foc...
Autores principales: | Shuai, You, Ma, Zhonghua, Ju, Jie, Wei, Tong, Gao, Songlin, Kang, Yikun, Yang, Zixuan, Wang, Xue, Yue, Jian, Yuan, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644618/ https://www.ncbi.nlm.nih.gov/pubmed/37957623 http://dx.doi.org/10.1186/s12967-023-04660-z |
Ejemplares similares
-
Clinicopathologic characteristics and prognostic significance of HER2-low expression in patients with early breast cancer: A systematic review and meta-analysis
por: Wei, Tong, et al.
Publicado: (2023) -
Circulating tumour DNA — looking beyond the blood
por: Tivey, Ann, et al.
Publicado: (2022) -
Looking beyond
por: Park, Kwangsung
Publicado: (2015) -
The antimalarial screening landscape—looking beyond the asexual blood stage
por: Yahiya, Sabrina, et al.
Publicado: (2019) -
Looking beyond the LHC
Publicado: (2009)